Key facts
- This page summarizes Big Rock Partners Sponsor, LLC's Form 4 filing for NRX Pharmaceuticals, Inc. (NRXP).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 25 May 2021, 21:17.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Disposed to Issuer
Conversion of derivative security
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Conversion of derivative security
Purchase
Additional SEC filing notes
Section 16 status
Big Rock Partners Sponsor, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
Mr. Ackerman is the managing member of this entity and has the sole voting and dispositive power of the securities held thereby. Accordingly, Mr. Ackerman may be deemed to have beneficial ownership of such shares. Mr. Ackerman disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Footnote F2
Each of the Issuer's Rights were convertible into 1/10 of one share of the Issuer's common stock upon consummation of the Issuer's initial business combination and had no expiration date. In connection with the Issuer's business combination, such Rights automatically converted into shares of common stock.
Footnote F3
Mr. Ackerman is the majority owner of this entity and may be deemed to have beneficial ownership of the shares owned thereby. Mr. Ackerman disclaims beneficial ownership except to the extent of his pecuniary interest therein.